Intarcia, Boston, MA

Intarcia

www.intarcia.com

We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking. We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved. We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases. Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine.

Number of Employees: 100-250
Annual Revenue: $10-50 Million

www.intarcia.com
One Marina Park Drive 13 Floor
Boston, MA USA 02210
Phone: 617.936.2500

Executives

Name	Title	Contact Details
Nalin Narayanam	Chief Information Security Officer	Profile
Anders Vinther	Global Head of Technical Operations	Profile
Andrew Palan	Chief Information Officer	Profile
Andrew Palan	‎Chief Information Officer	Profile

Funding

Intarcia raised $215M on 09/15/2016

Intarcia raised $206M on 01/02/2017

Similar Companies

Elan

Elan is a biotechnology company, headquartered in Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world.

BioGenex Laboratories, Inc.

BioGenex Laboratories, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

CPS Instruments

CPS Instruments is a Stuart, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kiniksa Pharmaceuticals

Our Story Kiniksa’s goal is to build a fully-integrated biopharmaceutical company. Our management team and employees are focused on advancing a portfolio of immune-modulating, clinical-stage product candidates that target underserved conditions and off...

Kriya Therapeutics

Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases.